TY  - JOUR
AU  - León Jiménez, David
AU  - Cherney, David Z I
AU  - Bjornstad, Petter
AU  - Castilla-Guerra, Luis
AU  - Miramontes González, José Pablo
PY  - 2018
DO  - 10.1152/ajprenal.00384.2017
UR  - http://hdl.handle.net/10668/12786
T2  - American journal of physiology. Renal physiology
AB  - While sodium-glucose cotransporter-2 (SGLT2) inhibitors have been used for the routine management of type 2 diabetes for several years, it is perhaps their natriuretic effects that are most important clinically. This natriuresis activates...
LA  - en
KW  - albuminuria
KW  - anhidrasa carbonic
KW  - diabetic kidney disease
KW  - natriuresis
KW  - sodium glucose type 2 inhibitor
KW  - Animals
KW  - Biomarkers
KW  - Blood Glucose
KW  - Diabetes Mellitus, Type 2
KW  - Diabetic Nephropathies
KW  - Dipeptidyl-Peptidase IV Inhibitors
KW  - Humans
KW  - Incretins
KW  - Kidney
KW  - Natriuresis
KW  - Sodium-Glucose Transporter 2
KW  - Sodium-Glucose Transporter 2 Inhibitors
KW  - Treatment Outcome
TI  - Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease.
TY  - research article
VL  - 315
ER  -